Home > Riviste > Minerva Ginecologica > Fascicoli precedenti > Minerva Ginecologica 2014 June;66(3) > Minerva Ginecologica 2014 June;66(3):299-301

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA GINECOLOGICA

Rivista di Ostetricia e Ginecologia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

ARTICOLI ORIGINALI  


Minerva Ginecologica 2014 June;66(3):299-301

lingua: Inglese

Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome

Leanza V., Coco L., Grasso F., Leanza G., Zarbo G., Palumbo M.

Obstetric and Gynecology, Department Of Surgery, Catania University, Italy


PDF  


AIM: Polycystic ovary syndrome (PCOS) is one of the most common causes of ovulatory infertility. It is an endocrine disorders characterized by a high level of male hormones (androgens) and frequent anovulatory cycles associated with multiple ovarian microcysts. The aim of this paper was to evaluate effects of a Clomiphene citrate alone versus a combined treatment (Metformin and Clomiphene citrate).
METHODS: A total of 60 women with PCOS and infertility were evaluated. Inclusions criteria were: age 26-34 years, nulliparity, above 3 years of sterility, multiple ovarian microcysts, BMI>27.5, oligomenorrhea/amenorrhea, hyperandrogenism and normal male fertility. Four patients were excluded (renal damage 2, tubal occlusion 1 and Pelvic Inflammatory Disease 1). The remaining 56 were divided into 2 groups: group A were inducted with Clomiphene Citrate alone, while group B were inducted with Clomiphene citrate and Metformin.
RESULTS: In group A we obtained ovulation in 20 women (71.4%), 8 pregnancies (28.5%) and one (3.5%) spontaneous abortion. In group B we obtained ovulation in 24 women (85.7%), 15 pregnancies (53.5%) and no spontaneous abortions.
CONCLUSION: Combined treatment was found to be more effective (53.5) in improving pregnancy rate compared to monotherapy (28.5%).

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

federicagrasso88@gmail.com